Literature DB >> 30469059

Early childhood exposure to maternal smoking and Kawasaki Disease: A longitudinal survey in Japan.

Takashi Yorifuji1, Hirokazu Tsukahara2, Hiroyuki Doi3.   

Abstract

Kawasaki disease is the leading cause of acquired childhood heart disease in most developed countries, but the etiology of the disease is unknown. An aberrant immune response to some environmental triggers may play a role and involuntary exposure to tobacco smoke can alter immune functions. We thus prospectively examined the association between early childhood exposure to maternal smoking and the incidence of Kawasaki disease. We used a large, nationwide population-based longitudinal survey ongoing since 2010 and restricted participants to a total of 38,444 children for whom information on maternal smoking was available. Maternal smoking status was ascertained at 6months of age, and responses to questions about hospital admission for Kawasaki disease between the ages of 6 and 30months were used as outcome. We conducted binomial log-linear regression analyses adjusting for children's, parental, and residential factors with children of non-smoking mothers as our reference group. Maternal smoking increased the risk of admission, in particular for the period between 6 and 18months of age, in a dose-dependent manner. Compared with children of non-smoking mothers, the children of mothers who smoked had a risk ratio of 1.83 (95% confidence interval: 1.06, 3.35) for hospital admissions between 6 and 30months of age and a risk ratio of 2.69 (95% confidence interval: 1.56, 4.64) for hospital admissions between 6 and 18months of age. Early childhood exposure to maternal smoking may increase the risk of Kawasaki disease hospitalizations in childhood.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Early childhood exposure; Epidemiology; Mucocutaneous lymph node syndrome; Smoking

Mesh:

Year:  2018        PMID: 30469059     DOI: 10.1016/j.scitotenv.2018.11.194

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

1.  Evaluating the time-varying risk of hypertension, cardiac events, and mortality following Kawasaki disease diagnosis.

Authors:  Jennifer J Y Lee; Brian M Feldman; Brian W McCrindle; Ping Li; Rae Sm Yeung; Jessica Widdifield
Journal:  Pediatr Res       Date:  2022-08-24       Impact factor: 3.953

2.  Neonatal sepsis and Kawasaki disease.

Authors:  Akihito Takeuchi; Noriko Sugino; Takahiro Namba; Kei Tamai; Kazue Nakamura; Makoto Nakamura; Misao Kageyama; Takashi Yorifuji; Motoki Bonno
Journal:  Eur J Pediatr       Date:  2022-05-16       Impact factor: 3.860

3.  Involvement of p53, p21, and Caspase-3 in Apoptosis of Coronary Artery Smooth Muscle Cells in a Kawasaki Vasculitis Mouse Model.

Authors:  Minghong Deng; Chunwang Lin; Xianglin Zeng; Jianping Zhang; Fang Wen; Ziguang Liu; Haiyan Wu; Xiaofeng Wu
Journal:  Med Sci Monit       Date:  2020-08-21

4.  Breastfeeding and vitamin D supplementation reduce the risk of Kawasaki disease in a German population-based case-control study.

Authors:  K Meyer; A Volkmann; M Hufnagel; E Schachinger; S Klau; J Horstmann; R Berner; M Fischer; A Lehner; N Haas; S Ulrich; A Jakob
Journal:  BMC Pediatr       Date:  2019-02-26       Impact factor: 2.125

Review 5.  Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Authors:  Wendy Lee; Chooi San Cheah; Siti Aisyah Suhaini; Abdullah Harith Azidin; Mohammad Shukri Khoo; Noor Akmal Shareela Ismail; Adli Ali
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

6.  Exposures associated with the onset of Kawasaki disease in infancy from the Japan Environment and Children's Study.

Authors:  Sayaka Fukuda; Shiro Tanaka; Chihiro Kawakami; Tohru Kobayashi; Shuichi Ito
Journal:  Sci Rep       Date:  2021-06-25       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.